A.I. BURNASYAN FMBC CLINICAL BULLETIN

ISSN 2782-6430 (print)

State Research Center −Burnasyan Federal Medical Biophysical
Center of Federal Medical Biological Agency

The journal is published in Russian.
Format – A4.
The periodicity of the journal is 4 times a year.

Issue №2 2025 год

more

A.I. Burnasyan  FMBC clinical bulletin. 2024 № 3

K.M. Badykova1, Y.S. Kitaeva1,2, E.A. Praskurnichij1,3, T.V. Stasyuk1

Risk Factors for Osteoporosis in Patients with Hodgkin’s Lymphoma. Literature Review

1International Office, State Research Center – Burnasyan Federal Medical Biophysical Center  of Federal Medical Biological Agency, Moscow, Russiа

2Federal State Budgetary Institution of Higher Professional Education «Urals State Medical University» of the Ministry of Healthcare of the Russian Federation, Ekaterinburg, Russia

3Pirogov Russian National Research Medical University, Moscow, Russia

Contact person: Badykova Kseniya Mikhaylovna: badykova.gem@gmail.com

Abstract
Hodgkin’s lymphoma is a malignant neoplasm of lymphoid tissue that develops mainly between the ages of 15 and 45 years. Thanks to the successes in the development of modern oncohematology, today the proportion of complete remissions among patients reaches 90%. However, excellent survival rates also come with a high risk of long-term complications, one of which is decreased bone mineral density, including osteoporosis. Dynamic processes of modeling and remodeling continuously occur inside the bone, which depend on many internal and external factors acting in different directions. In patients with an established diagnosis of Hodgkin’s lymphoma, there are risk factors specific to this category of patients: the effect on the body of the tumor process and highly toxic chemotherapy drugs as part of pathogenetic treatment; and nonspecific, widespread throughout the population. Among the nonspecific factors, this review identified and examined gender, weight-to-height ratio, smoking and alcohol abuse, physical inactivity, as well as the presence of osteoporosis and fractures in the family history. The development of osteoporosis in patients with Hodgkin’s lymphoma as a subject of discussion is still only gaining interest among researchers. Differentiation of risk factors for decreased bone mineral density in this category of patients is a very pressing problem in the current reality of the lack of official clinical recommendations for the diagnosis and prevention of osteoporosis in young patients with Hodgkin lymphoma, and also due to the small amount of published material on this topic.

Keywords: Hodgkin’s lymphoma, osteoporosis, bone mineral density, risk factors

For citation: Badykova KM, Kitaeva YS, Praskurnichij EA., Stasyuk TV. Risk Factors for Osteoporosis in Patients with Hodgkin’s Lymphoma. Literature Review. A.I. Burnasyan Federal Medical Biophysical Center Clinical Bulletin. 2024.3:63-72. (In Russian) DOI: 10.33266/2782-6430-2024-3-63-72

 

REFERENCES

  1. Demina E.A. Rukovodstvo po Lecheniyu Limfomy Xodzhkina = Hodgkin Lymphoma Treatment Guide. Moscow, Re Media Publ., 2021. 96 p. (In Russ.).
  2. Kovrigina A.M. Hodgkin’s Lymphoma: Issues of Etiology and Pathogenesis (Literature Review). Rossiyskiy Bioterapevticheskiy Zhurnal = Russian Journal of Biotherapeutics. 2005;4:10-18 (In Russ.).
  3. Demina E.A., Tumyan G.S., Moiseeva T.S., Mikhaylova N.B, Myakova N.V., Rumyantsev A.G., et al. Hodgkin’s Lymphoma. Sovremennaya Onkologiya = Journal of Modern Oncology. 2018;22;2:6-33 (In Russ).
  4. Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France. International Agency for Research in Cancer (IARC) Publ., 2017. 423 p.
  5. Kaprin A.D., Starinskiy V.V., Shakhzadova A.O. Zlokachestvenny`e Novoobrazovaniya v Rossii v 2021 godu (Zabolevaemost` i Smertnost`) = Malignant Neoplasms in Russia in 2021 (Incidence and Mortality). Moscow Publ., 2022. 252 p. (In Russ.).
  6. Engert A., Plutschow A., Eich H. Lohri A., Dorken B., Borchmann P., et al. Reduced Treatment Intensity in Patients with Early-Stage Hodgkin’s Lymphoma. The New England Journal of Medicine. 2010;363;7:640-652.
  7. Glossman J.P., Josting A., Diehl V. New Treatments for Hodgkin’s Disease. Current Treatment Options in Oncology. 2002;3;4:283-90.
  8. Danilenko A.A. Otdalennyye Posledstviya Luchevoy i Khimioluchevoy Terapii Pervichnykh Bol’nykh Limfomoy Khodzhkina = Remote Consequences Of Radiation And Chemoradiation Therapy in Primary Patients With Hodgkin’s Lymphoma. Doctor’s Thesis in Medicine. Obninsk Publ., 2017 (In Russ.).
  9. Belaya Zh.E., Belova K.Yu., Biryukova E.V., Dedov I.I., Dzeranova L.K., Drapkina O.M., et al. Federal Clinical Guidelines for the Diagnosis, Treatment and Prevention of Osteoporosis. Osteoporoz i Osteopatii = Osteoporosis and Osteopathy. 2021;24;2:4-47 (In Russ.).
  10. Camacho P.M., Petak S.M., Binkley N., Clarke B.L., Harris S.T., Hurley D.L., et al. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis. Endocrine Practice. 2016;22;4:1-42.
  11. Mirina E.Yu. Osteoporosis. Principles of Diagnosis and Treatment. Russkiy Meditsinskiy Zhurnal = Russian Medical Journal. 2012;13:638 (In Russ.).
  12. Kamilov F.X., Farshatova E.R., Enikeev D.A. Cellular and Molecular Mechanisms of Bone Tissue Remodeling and its Regulation. Fundamental`nye Issledovaniya = Fundamental Research. 2014;7;4:836-842 (In Russ.).
  13. Pikalyuk V.S., Mostovoy S.O. Modern Concepts of Biology and Function of Bone Tissue. Tavricheskiy Mediko-Biologicheskiy Vestnik = Tauride Medical and Biological Herald. 2006;9;3:186-194 (In Russ.).
  14. Scherbak I.G., Avrunin A.S., Tixilov R.M., Abolin A.B. Levels of Organization of the Mineral Matrix of Bone Tissue and Mechanisms that Determine the Parameters of their Formation. Morfologiya = Morphology. 2005;127;2:78-82 (In Russ.).
  15. Harada S., Rodan G.A. Control of Osteoblast Function and Regulation of Bone Mass. Nature. 2003;423;6937:349-355.
  16. Avrunin A.S., Tixilov R.M Osteocytic Remodeling of Bone Tissue: History of the Issue, Morphological Markers. Morfologiya = Morphology. 2011;139;1:86-95 (In Russ.).
  17. Melnichenko G.A., Belaya Zh.E., Rozhinskaya L.Ya., Toroptsova N.V., Alekseeva L.I., Biryukova E.V., et al. Federal Clinical Guidelines for the Diagnosis, Treatment and Prevention of Osteoporosis. Problemy Endokrinologii = Problems of Endocrinology. 2017;63;6:392-426 (In Russ.).
  18. Sveshnikov A.A. Mineral`Naya Plotnost` Kostej Skeleta, Massa Myshts i Problemy` Profilaktiki Perelomov = Bone Mineral Density, Muscle Mass and Fracture Prevention Issues. Monograph. Moscow, The Russian Academy of Natural Sciences Publ., 2013. 365 p. (In Russ.).
  19. Kuznetsova I.V., Chilova R.A. Menopausal Osteoporosis in the Practice of a Gynecologist. Meditsinskiy Sovet = Medical Advice. 2021;12:320-331 (In Russ.).
  20. Postnikova S.L. Features of Postmenopausal Osteoporosis. Lechebnoe Delo = Medical Practice. 2004;4:41-45 (In Russ.).
  21. Ershova O.B., Sinitsina O.S., Belova K.Yu., Ganert O.A., Romanova M.A., Nazarova A.V. The Influence of Hormonal Status on the Development of Osteoporosis and Bone Fractures in Men (Literature Review). Meditsinskiy Sovet = Medical Advice. 2013;3:72-75 (In Russ.).
  22. Leder B.Z, LeBlanc K.M., Schoenfeld D.A., Eastell R., Finkelstein J.S. Differential Effects of Androgens and Estrogens on Bone Turnover in Normal Men. The Journal of Clinical Endocrinology and Metabolism. 2003;88;1:204-210.
  23. Mohr B.A., Guay A.T., O’Donnell A.B., McKinlay J.B. Normal, Bound and Nonbound Testosterone Levels in Normally Ageing Men: Results from the Massachusetts Male Ageing Study. Clinical Endocrinology (Oxford). 2005;62;1:64-73.
  24. Litman H.J., Bhasin S, Link C.L., Araujo A.B., McKin-lay J.B. Serum Androgen Levels in Black, Hispanic, and White Men. The Journal of Clinical Endocrinology and Metabolism. 2006;91;11:4326-34.
  25. Golovach I.Yu., Egudina E.D. Osteoporosis in Men: State of the Problems, Risk Factors, Diagnostics, Modern Approaches to Individuals. Travma = Trauma. 2018;19;5:5-19 (In Russ.).
  26. Muller M, den Tonkelaar I., Thijssen J.H., Grob-bee D.E., van der Schouw Y.T. Endogenous Sex Hormones in Men Aged 40-80 Years. The European Journal of Endocrinology. 2003;149;6:583-589.
  27. Meier C., Nguyen T.V., Handelsman D.J., Schindler C., Kushnir M.M., Rockwood A.L., et al. Endogenous Sex Hormones and Incident Fracture Risk in Older Men. The Dubbo Osteoporosis Epidemiology Study. Archives of Internal Medicine. 2008;168;1:47-54.
  28. Krutikova N.Yu., Efremenkova A.S. Modern Concepts of the Influence of Adipose Tissue on the Regulation of Bone Metabolism. Prakticheskaya Meditsina = Practical Medicine. 2020;18;6:69-72 (In Russ.).
  29. De Laet C., Kanis J.A., Oden A., Johanson H., Johnell O., Delmas P. Body Mass Index as a Predictor of Fracture Risk: a Meta-Analysis. Osteoporosis International. 2005;16;11:1330-8.
  30. Mixaylin A.I. On the Issue of Assessing the Risk of Developing Osteoporosis. Byulleten Natsionalnogo Nauchno-Issledovatelskogo Instituta Obshchestvennogo Zdorovya imeni N.A.Semashko = Bulletin of Semashko National Research Institute of Public Health. 2012;4:101-103 (In Russ.).
  31. Asomaning K., Bertone-Johnson E.R., Nasca P.C., Hooven F., Pekow P.S. The Association between Body Mass Index and Osteoporosis in Patients Referred for a Bone Mineral Density Examination. 2006;15;9:1028-34.
  32. Shishkova V.N. Obesity and Osteoporosis. Osteoporoz i Osteopatii = Osteoporosis and Osteopathies. 2011;1:21-6 (In Russ.)
  33. Xiang B.Y., Huang W., Zhou G.Q., Hu N., Chen H., Chen C. Body Mass Index and the Risk of Low Bone Mass-Related Fractures in Women Compared with Men: a Prisma-Compliant Meta-Analysis of Prospective Cohort Studies. Medicine (Baltimore). 2017;96;12:e5290.
  34. Reid I.R. Relationships among Body Mass, its Components, and Bone. Bone 2002;31;5:547-55.
  35. Dedov I.I., Melnichenko G.A. Ozhirenie: Etiologiya, Patogenez, Klinicheskie Aspekty = Obesity: Etiology, Pathogenesis, Clinical Aspects. Moscow, MIA Publ., 2006. 456 p. (In Russ.).
  36. Papakitsou E.F., Margioris A.N., Dretakis K.E. Trovas G., Zoras U., Lyritis G., et al. Body Mass Index (BMI) and Parameters of Bone Formation and Resorption in Postmenopausal Women. Maturitas. 2004;47;3:185-93.
  37. Weisberg S.P., McCann D., Desai M. Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is Associated with Macrophage Accumulation in Adipose Tissue. The Journal of Clinical Investigation. 2003;112;12:1796-1808.
  38. Ganieva I.I., Karabinenko A.A., Eremina C.S., Urvanceva O.M., Storozhakov G.I. The Impact of Smoking on Bone Tissue. The State of the Problem. Lechebnoe Delo = Medical Practice 2013;1:4-8 (In Russ.).
  39. Rodionova S.S., Khakimov U.R. The Effect of Smoking on Bone Metabolism in Idiopathic Osteoporosis in Men. Osteoporoz i Osteopatii = Osteoporosis and Osteopathies. 2020;2:135 (In Russ.).
  40. Michnovicz J.J., Hershcopf R.J., Naganuma H., Bradlow H.L., Fishman J. Increased 2-Hydroxylation of Estradiol as a Possible Mechanism for the Anti-Estrogenic Effect of Cigarette Smoking. The New England Journal of Medicine. 1986;315;21:1305-1309.
  41. Conney A.H. Pharmacological Implications of Microsomal Enzyme Induction. Pharmacological Reviews. 1967;19;3:317-366.
  42. Goryachev D.N., Mukhamedzhanova L.R. Mechanisms of Development of Alcohol-Dependent Osteoporosis. Kazanskiy Meditsinskiy Zhurnal = Kazan Medical Journal. 2012;93;1:120-122 (In Russ.).
  43. Bazhenov Yu.I., Bazhenova A.F., Volkova Ya.Yu. The Effect of Ethanol on Physiological Functions of the Body. Vestnik Ivanovskogo Gosudarstvennogo Universiteta = Bulletin of Ivanovo State University. 2002;3:3-14 (In Russ.).
  44. Nasonov E.L. Problems of Osteoporosis in Men. Russkiy Meditsinskiy Zhurnal = Russian Medical Journal. 2003;11;23:56-59 (In Russ.).
  45. Rodionova S.S., Khakimov U.R., Morozov A.K., Krivova A.V. Smoking and Alcohol Abuse as Risk Factors for Low-Energy Fractures in Primary Osteoporosis in Men. Analiz Riska Zdorov`yu = Health Risk Analysis. 2020;2:126-134 (In Russ.).
  46. Sveshnikov A.A., Smotrova L.A., Ovchinnikov E.N. Mechanisms of Bone Tissue Demineralization. Geniy Ortopedii = Genius of Orthopedics. 2005;2:95-99 (In Russ.).
  47. Oganov V.S. Research on Gravitational Physiology of the Skeleton and the Problem of Osteoporosis. Rossiyskiy Fiziologicheskiy Zhurnal = Russian Physiological Journal. 2003;89;3: 347-345 (In Russ.).
  48. Orlov O.I. Prevention of Calcium Metabolism Disorders and its Regulation Systems during Prolonged Hypokinesia with Human Participation. Osteoporoz i Osteopatii = Osteoporosis and Osteopathy. 2007;3:21-23 (In Russ.).
  49. Karpova N.Yu., Rashid M.A., Kazakova T.V., Yadrov M.E. Calcium Metabolism and Bone Homeostasis. Farmateka = Pharmateca. 2016;16;3:16-21 (In Russ.).
  50. Harris S.S., Nguyen T.V., Kelly P.J., Eisman J.A., Howard G.M. Genetic and Environmental Correlation Between Bone Formation and Bone Mineral Density: a Twin Study. Bone. 1998;22;2:141-145.
  51. Gel’tser B.I., Kochetkova E.A., Bubnov O.Yu., Vasil’yeva T.G., Belykh O.A. Genetics of Osteoporosis: a Modern View of the Problem (Literature Review). Acta Biomedica Scientifica. 2005;42;4:170-174 (In Russ.).
  52. Korotkova T.A. The Influence of Genetic and Environmental Factors on the Formation of Peak Bone Mass in Adolescents. Osteoporoz i Osteopatii = Osteoporosis and Osteopathy. 2004;3:34-37 (In Russ.).
  53. Myakotkin V.A. Benevolenskaya L.I. Genetics of Osteoporosis. Vestnik Rossiyskoy Akademii Nauk = Bulletin of the Russian Academy of Sciences. 2008;6:27-29 (In Russ.).
  54. McGuigan F.E., Murray L., Gallagher A., Davey-Smith G., Neville C.E., Van’t Hof R. Genetic and Environmental Determinants of Peak Bone Mass in Young Men and Women. Journal of Bone and Mineral Research. 2002;17;7:1273-9.
  55. Efstathiadou Z., Tsatsoulis A., Ioannidis J.P. Association of Collagen Ialpha 1 Sp1 Polymorphism with the Risk of Prevalent Fractures: a Meta-Analysis. Journal of Bone and Mineral Research. 2001;16;9:1586-92.
  56. Baranova I.A. Risk Factors for Osteoporosis. Prakticheskaya Pul’monologiya = Practical Pulmonology. 2004;4:18-22 (In Russ.).
  57. Ketlinskiy S.A., Simbirtsev A.S. Tsitokiny = Cytokines. Monograph. St. Petersburg, Foliant Publ., 2008. 549 p. (In Russ.).
  58. Skvortsova N.V., Pospelova T.I., Kovynev I.B., Obgol’ts Yu.N., Nechunayeva I.N. Clinical Significance of some Cytokines and their Prognostic Role in Patients with Non-Hodgkin’s Malignant Lymphomas. Byulleten’ Sibirskoy Meditsiny = Bulletin of Siberian Medicine. 2008;7;3:63-70 (In Russ.).
  59. Chukichev A.V., Dolgushin I.I., Zlakomanova O.N., Chepurov Yu.I. Cytokine Imbalance and Bone Metabolism Markers in the Posttraumatic Period in Children. Detskaya Khirurgiya = Pediatric Surgery. 2007;6:9-13 (In Russ.).
  60. Nakamura I., Jimi E. Regulation of Osteoclast Differentiation and Function by Interleukin-1. Vitamins and Hormones. 2006;74:357-370.
  61. Korshunova E.Yu., Dmitrieva L.A., Lebedev V.F. Cytokine Regulation of Bone Tissue Metabolism. Politravma = Polytrauma. 2012;3:82-86 (In Russ.).
  62. Manolagas S.C., Jilka R.L. Bone Marrow, Cytokines, and Bone Remodeling. Emerging Insights into the Pathophysiology of Osteoporosis. The New England Journal of Medicine. 1995;332;5:305-11
  63. Ura K., Morimoto I., Watanabe K. Interleukin (IL)-4 and IL-13 Inhibit the Differentiation of Murine Osteoblastic MC3T3-E1 Cells. Endocrine Journal. 2000;47;3:293-305.
  64. Kohara H., Kitaura H., Fujimura Y., Yoshimatsu M., Morita Y., Eguchi T., et al. IFN-gamma Directly Inhibits TNF-Alpha-Induced Osteoclastogenesis in Vitro and in Vivo and Induces Apoptosis Mediated by Fas/Fas Ligand Interactions. Immunology Letters. 2011;137;1–2:53–61.
  65. Van’t Hof R.J., Ralston S.H. Cytokine-Induced Nitric Oxide Inhibits Bone Resorption by Inducing Apoptosis of Osteoclast Progenitors and Suppressing Osteoclast Activity. Journal of Bone and Mineral Research. 1997;12;11:1797–804.
  66. Hofbauer L.C., Gori F., Riggs B.L., Lacey D.L., Dunstan C.R., Spelsberg T.C., et al. Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis. Endocrinology. 1999;140;10:4382-9.
  67. Baranova I.A. Glucocorticoid Induced Osteoporosis: Pathogenesis, Prevention, Treatment. Sovremennaya Revmatologiya = Modern Rheumatology. 2008;1:31-39 (In Russ.).
  68. Davies J.H., Evans B.A., Jenney M.E., Gregory J.W. In Vitro Effects of Combination Chemotherapy on Osteoblasts: Implications for Osteopenia in Childhood Malignancy. Bone. 2002;31;2:319-326.
  69. Voytko M.S., Pospelova T.I., Klimontov V.V., Mezit Ye.V. Factors Affecting Bone Remodeling in Patients with Hodgkin’s Lymphoma (Literature Review). Sibirskiy Nauchnyy Meditsinskiy Zhurnal = Siberian Scientific Medical Journal. 2018;.38;4:65-72 (In Russ.).
  70. Behringer К., Вrеuеr К., Remeke Т. May M., Nogova L. Klimm B., et al. Secondary Amenorrhea after Hodgkin’s Lymphoma is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives During Therapy a Report from the German Hodgkin’s Lymphoma Study Group. Journal of Clinical Oncology. 2005;23;30:7555-64.
  71. Blumenfeld Z., Dann E., Avivi I. Fertility after Treatment for Hodgkin’s Disease. Annals of Oncology. 2002;13;1:138-1347.
  72. Sklar C. Maintenance of Ovarian Function and Risk of Premature Menopause Related to Cancer Treatment. Journal of the National Cancer Institute. 2005;34:25-7.
  73. Shapiro C.L., Manola J., Leboff M. Ovarian Failure after Adjuvant Chemotherapy is Associated with Rapid Bone Loss in Women with Early-Stage Breast Cancer. Journal of Clinical Oncology. 2001;19;14:3306-11.
  74. Redmann J.R., Bajorunas D.R., Goldstein M.C., Evenson D.P., Gralla R.J., Lacher M.J., et al. Semen Cryopreservation and Artificial Insemination for Hodgkin’s Disease. Journal of Clinical Oncology. 1987;5:233-8.
  75. Viviani S., Santoro A., Ragni G. Bonfante V., Bestetti O., Bonadonna G. Gonadal Toxicity after Combination Chemotherapy for Hodgkin’ Disease. Comparative Results of MOPP vs ABVD. European Journal of Cancer. 1985;21:601-5.
  76. Kreuser E. D. Impact of Chemotherapy and Radiation on Gonadal and Sexual Functions in Patients Treated for Malignant Tumors. 21st ESMO Congress. Vienna, Austria, 1996:79-83.
  77. Chapman M., Perry M.C. Gonadal Toxicity and Teratogenicity. In: the Chemotherapy Source Book. Baltimore: Williams and Wikins, 1992:710-53.
  78. Quach J.M., Askmyr M., Jovic T., Baker E.K., Walsh N.C. Harrison J.S., et al. Myelosuppressive Therapies Significantly Increase Pro-Inflammatory Cytokines and Directly Cause Bone Loss. Journal of Bone and Mineral Research. 2015;30;5:886-97.

Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 13.06.2024. Accepted for publication: 11.07.2024

© 2025 Scientific journal - "Clinical Bulletin of the FMBС im. A.I. Burnasyan"
Scroll to Top